Company intelligence / Profile preview

Neuro-Xplore

Ownership: Private
Development stage: Preclinical

Overview

Neuro-Xplore specializes in providing consulting services for preclinical research in neuropharmacology, central nervous system disorders, rare neurological diseases, and psychiatric conditions. The company helps design robust preclinical studies, interpret complex data, and guide go/no-go decisions to accelerate drug discovery and development. It does not appear to have its own clinical pipeline or published clinical results but rather supports other biotech companies with expertise in neuroscience R&D.

Therapeutic areas: PsychiatryNeurology
Modalities: Small moleculeBiologicAntibodyPeptides
Industry: Drug Discovery Services

Partnerships

Not specified; likely collaborates with biotech companies and foundations as a consultant/advisor

Beyond the preview

Go deeper on Neuro-Xplore.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuro-Xplore.

Explore the full profile